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One sentence summary: In our study are described for first time the application of the PCR fingerprinting to distinguish all species, clinical and
environmental, of an important fungic complex, Sporothrix spp.
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ABSTRACT
In this study, PCR fingerprinting using the universal primer T3B was applied to distinguish among clinical and
environmental species of the Sporothrix complex, Sporothrix brasiliensis, S. globosa, S. mexicana, S. pallida, S. luriei and S.
schenckii sensu stricto. The T3B fingerprinting generated clearly distinct banding patterns, allowing the correct identification
of all 43 clinical and environmental isolates at the species level, what was confirmed by partial calmodulin gene sequence
analyses. This technique is reproducible and provides the identification of all species of the Sporothrix complex with
sufficient accuracy to be applied in clinical mycology laboratories as well as in epidemiological studies in order to obtain a
better understanding of the epidemiology of sporotrichosis.
15
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INTRODUCTION
Sporotrichosis is a chronic, granulomatous subcutaneousmyco-
sis caused by pathogenic species in the Sporothrix schenckii com-
plex. This infection is globally distributed, being Latin America,25
South Africa, India, China and Japan areas of high endemicity
(Lopez-Romero et al. 2011; Queiroz-Telles et al. 2011; Song et al.
2013). Sporotrichosis occurs mainly through traumatic inocula-
tion of fungal propagules into the skin by contaminated mate-
rial, such as soil, plant thorns or splinters, being regarded as a30
job-related disease occurring in the form of isolated cases or
small outbreaks affecting people exposed to plants or organic
matter rich soil (Cooper, Dixon and Salkin 1992; Hajjeh et al. 1997;
Zancope´-Oliveira et al. 2011). Sporotrichosis affects humans and
animals, and its zoonotic potential has been well exempli- 35
fied in outbreaks in Brazil due to animal scratches and bites
(Schubach, Barros andWanke 2008; Zancope´-Oliveira et al. 2011).
Rio de Janeiro in Brazil has been reported as a hyperendemic
region since, from 1997 to 2007, 1848 cases of human sporotri-
chosis occurred in that state (Schubach, Barros and Wanke 40
2008; Silva et al. 2012). Curiously, 83.4% of the human infections
were associated with prior contact with infected cats (Schubach,
Barros and Wanke 2008). This route of infection contrasts
markedly with other sporotrichosis reports which have been
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Table 1. Polyphasic taxonomy in characterization of strains of the Sporothrix complex and comparison with tool of T3B fingerprinting.
Strain Final identification$ Source Genbank no References∗∗∗
IPEC16490 S. brasiliensis Clinical AM116899 Oliveira et al. (2011)
IPEC27445-3 S. brasiliensis Clinical HQ426950 Oliveira et al. (2012)
IPEC27052 S. brasiliensis Clinical HQ426941 Oliveira et al. (2012)
IPEC27135 S. globosa Clinical GU456632 Oliveira et al. (2010)
INSA378027 S. globosa Clinical KF437620 Oliveira et al. (2014)
IPEC27387 S. brasiliensis Clinical HQ426948 Oliveira et al. (2011)
IPEC34067 S. brasiliensis Clinical HQ426952 Oliveira et al. (2011)
IPEC27372 S. brasiliensis Clinical HQ426947 Oliveira et al. (2011)
IPEC25011 S. brasiliensis Clinical HQ426935 Oliveira et al. (2011)
IPEC33605 S. brasiliensis Clinical HQ426957 Oliveira et al. (2011)
IPEC27930 S. brasiliensis Clinical HQ426951 Oliveira et al. (2011)
IPEC28772 S. brasiliensis Clinical HQ426955 Oliveira et al. (2011)
IPEC28457 S. brasiliensis Clinical JN995607 Oliveira et al. (2012)
IPEC34007 S. brasiliensis Clinical HQ426959 Oliveira et al. (2012)
IPEC27177-2 S. brasiliensis Clinical HQ426944 Oliveira et al. (2011)
IPEC27087 S. brasiliensis Clinical HQ426942 Oliveira et al. (2011)
IPEC27288 S. brasiliensis Clinical HQ426945 Oliveira et al. (2011)
IPEC27209 S. brasiliensis Clinical HQ426946 Oliveira et al. (2011)
IPEC28604 S. brasiliensis Clinical HQ426953 Oliveira et al. (2011)
IPEC26945 S. brasiliensis Clinical HQ426939 Oliveira et al. (2011)
IPEC27130 S. brasiliensis Clinical HQ426943 Oliveira et al. (2011)
IPEC25521 S. brasiliensis Clinical HQ426936 Oliveira et al. (2011)
IPEC16919 S. brasiliensis Clinical HQ426930 Oliveira et al. (2011)
IPEC18782A S. brasiliensis Clinical HQ426933 Oliveira et al. (2012)
IPEC28329 S. brasiliensis Clinical JN995610 Oliveira et al. (2012)
IPEC27022 S. brasiliensis Clinical HQ426940 Oliveira et al. (2011)
IPEC28487 S. brasiliensis Clinical HQ426928 Oliveira et al. (2011)
IPEC27375 S. brasiliensis Clinical JN995606 Oliveira et al. (2012)
IPEC28790 S. brasiliensis Clinical HQ426956 Oliveira et al. (2011)
IPEC29334 S. schenckii Clinical HQ426962 Oliveira et al. (2011)
IPEC26961 S. schenckii Clinical JN995605 Oliveira et al. (2012)
IPEC27157-1 S. schenckii Clinical JN995604 Oliveira et al. (2012)
IPEC27100 S. brasiliensis Clinical JN995609 Oliveira et al. (2012)
IPEC27133 S. brasiliensis Clinical JN995608 Oliveira et al. (2012)
MUM 11.02 S. mexicana Clinical JF970258 Dias et al. (2011)
CBS937.72 S. luriei Clinical AM747302 Marimon et al. (2009)
BG6 S. pallida Environmental HQ692915 Romeo, Scordino and Criseo (2011)
BG S. pallida Environmental KJ472127 Romeo, Scordino and Criseo (2011)
BG2 S. pallida Environmental KJ472128 Romeo, Scordino and Criseo (2011)
SAM1 S. pallida Environmental KJ472130 Romeo, Scordino and Criseo (2011)
SPA8 S. pallida Environmental HQ686039 Romeo, Scordino and Criseo (2011)
SPA2 S. pallida Environmental KJ472129 Romeo, Scordino and Criseo (2011)
IPEC27722 S. schenckii Clinical HQ426961 Oliveira et al. (2011)
$ calmodulin sequencing and T3B identification concordant identification.
∗∗∗ Reference of partial gene calmodulin sequencing.
mainly associated with infection via a plant source, rather than45
by domestic cats infected with S. schenckii (Hay and Morris-Jones
2008; Freitas et al. 2010). Confirming the worldwide distribution
of the sporotrichosis, a large series of cases have been reported
in Jilin province, Northeast China, demonstrating an endemic
situation, with epidemiological and clinical characteristics sim-50
ilar to those of previous Chinese reports, but different from
those in other countries, as for example in Rio de Janeiro,
Brazil, where the endemia demonstrated zoonotic transmission
(Zancope´-Oliveira et al. 2011; Song et al. 2013).
Until 2007, S. schenckii was considered a single taxon, al-55
though Liu et al. (2003) had previously reported the existence of
high genetic variation within this species. Nowadays, it is rec-
ognized as S. schenckii complex comprising S. brasiliensis, S. glo-
bosa, S. mexicana and S. luriei (Marimon et al. 2007; Marimon et al.
2008a). Although geographic limitations are not precise, epi- 60
demiological data indicate that S. schenckii sensu stricto is found
predominantly on the American, Asian and African continents;
S. globosa has a worldwide distribution and it is found with high
frequency in Europe and Asia (Madrid et al. 2009; Oliveira et al.
2010, 2014; Yu et al. 2013). Sporothrix brasiliensis is apparently re- 65
stricted to Brazil (Marimon et al. 2007; Oliveira et al. 2011) while S.
mexicana seems to be mainly associated with Mexican environ-
mental samples (Marimon et al. 2007), although it has also been,
recently, identified in Portugal (Dias et al. 2011) and in Brazil (Ro-
drigues, de Hoog and de Camargo 2013). Sporothrix luriei is a very 70
rare pathogen, reported on four human sporotrichosis cases, but
isolated only from one case in Africa (Marimon et al. 2008a).
Phylogenetic analysis based on rDNA and the β-tubulin
sequence regions from S. albicans, S. pallida and S. nivea
de Oliveira et al. 3
Figure 1. Representative PCR fingerprinting profiles obtained with primer T3B for Sporothrix the species. Lanes 1 and 8 (1) molecular marker DNA ladder 100 base pair;
(2) S. globosa (IPEC 27135); (3) S. brasiliensis (IPEC 164904); (4) S. mexicana (MUM 11.02); (5) S. schenckii (IPEC27722); (6) S. pallida (SPA8); (7) S. luriei (CBS 937.72); (8) Negative
control.
revealed a high genetic similarity, and it was proposed to con-75
sider them as S. pallida (de Meyer et al. 2008). Until 2012, the
species S. pallida was considered as environmental species, but
a recent clinical report described its involvement in a case
of keratitis in the cornea of a transplant recipient (Morrison
et al. 2013).80
Currently, medically relevant Sporothrix spp. in the S. schenckii
complex are S. brasiliensis, S. schenckii s. str., S. globosa and S. luriei,
while S. mexicana and S. pallida are phylogenetically more re-
mote and, therefore, considered apart from the clinical group
(Zhou, Feng and de Hoog 2014). Recent studies showed that the85
different Sporothrix spp. differ in virulence and drug resistance
(Romeo and Criseo 2013). Sporothrix brasiliensis and S. schenckii
were shown to be the most virulent species, contrasting with
S. globosa and S. mexicana that showed little or no virulence in
a murine model of disseminated infection (Arrillaga-Moncrieff90
et al. 2009). Curiously, S. brasiliensis seems to be the most sus-
ceptible species to several antifungal agents, while S. mexicana
has been reported as the species most resistant showing only
a relatively low MIC (0.5 g ml−1) for terbinafine (Marimon et al.
2008b). Thus, once a culture is obtained, the identification to95
species level is mandatory because antifungal therapy can vary
according to the species.
The diagnosis of sporotrichosis is classically attained by cor-
relation of clinical, epidemiological and laboratorial data, in-
cluding culture and analysis of phenotypic characteristics. An 100
identification key for the Sporothrix species complex has been
proposed which included conidial morphology and auxono-
gram analysis, using raffinose and sucrose as carbon sources
(Marimon et al. 2007). However, identification based only on this
phenotypic key is often inconclusive, due to phenotypic variabil- 105
ity within the species (Oliveira et al. 2011; Rodrigues, de Hoog
and de Camargo 2013; Zhou, Feng and de Hoog 2014). A vari-
ety of polymerase chain reaction (PCR)-based assays using dif-
ferent targets have been developed to identify S. schenckii but
only few studies developed methodologies to distinguish more 110
than S. schenckii from the Sporothrix spp. complex (Kanbe et al.
2005; Oliveira et al. 2012). We recently described a PCR finger-
printing using the universal primer T3B to distinguish among
human pathogenic species of the Sporothrix complex, S. brasilien-
sis, S. globosa, S. mexicana and S. schenckii (Oliveira et al. 2012). 115
In addition, a PCR-RFLP using with target the calmodulin gene
digested with the restriction enzyme HhaI was reported, with
five different electrophoretic patterns representing the isolates
of Sporothrix species: S. brasiliensis, S. schenckii sensu stricto, S.
globosa and S. luriei. However, this PCR-RFLP protocol also not 120
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Figure 2. Dendrogram showing the degree of similarity of T3B fingerprinting profiles among the Sporothrix isolates by using the Dice coefficient and UPGMA cluster
method. Cophenetic correlation coefficient (0.97) indicates a very good fit for this analysis.
permitted identification of all isolates included in this complex
(Rodrigues, de Hoog and de Camargo 2014). Here, we evaluate
T3B PCR fingerprinting to differentiate environmental Sporothrix
strains at the species level in comparison to analysis of partial
calmodulin (CAL) gene sequences (Oliveira et al. 2010) and com-125
pared the obtained patterns with those previously identified in
clinical Sporothrix isolates.
A total of 43 Sporothrix spp. isolates (Table 1), including
the controls S. brasiliensis type strain CBS 120339 (IPEC16490)
(Marimon et al. 2007), S. globosa IPEC27135 (Oliveira 2010), S.130
schenckii s.str. IPEC29334 (IOC1226) (Oliveira et al. 2011), S. mexi-
cana (MUM11.02) (Dias et al. 2011), S. luriei CBS937.72 (Marimon
et al. 2008a) and S. pallida SPA8 (Romeo, Scordino and Criseo
2011) were used in this study. All strains were previously phe-
notypically and genotypically characterized at the species level 135
(Table 1).
Genomic DNA was extracted from the mycelial phase, and
PCR was performed with the primer T3B (5′-AGG TCG CGG
GTT CGA ATCC-3′) according to Oliveira et al. (2012). The re-
producibility of the method was confirmed by repeating the 140
T3B PCR fingerprinting assays at least three times under the
same conditions and in three different laboratories in Brazil, Por-
tugal and Italy. The T3B fingerprinting profiles obtained were
analyzed with Bionumerics (version 5.1; Applied Maths BVBA,
de Oliveira et al. 5
Figure 3. Neighbor-joining phylogram of the partial CAL gene obtained of all isolates of the study and S. mexicana, S. pallida, S. brasiliensis, S. schenckii, S. luriei and S.
globosa reference strains constructed with MEGA version 4.0.2. Bootstrap values after 1000 replicates are presented in the branch node.
Sint-Martens-Latem, Belgium). Similarity coefficients were cal-145
culated using the Dice algorithm and cluster analysis was per-
formed by means of the unweighted paired group method using
arithmetic averages (UPGMA). Partial calmodulin-encoding gene
(CAL) sequences were obtained from previous studies (Table 1),
edited with the Sequencer ver. 4.6 software package (Genes150
Codes Corporation, USA), and aligned with MEGA version 4.0.2
software (http://www.megasoftware.net/). Phylogenetic analy-
ses were performed by using MEGA software with bootstrap
analysis using 1000 replicates (Felsenstein 1985). All sequences
were deposited in the GenBank database under accession num-155
bers GU456632, HQ426928–HQ426962, JN995604–JN995610 and
KJ472127–KJ472130.
The T3B PCR fingerprinting of Sporothrix spp. control strains
showed profiles with DNA fragments ranging in size from 300
to 2800 bp, allowing the clear distinction of the strains from 160
S. brasiliensis, S. globosa, S. mexicana, S. schenckii, S. pallida and
S. luriei (Fig. 1). To confirm the taxonomic resolution of T3B am-
plification, the profiles of all isolates were analyzed. Although
intraspecies T3B profiles were not 100% similar, a band shar-
ing similarity higher than 80% was observed for S. brasiliensis 165
strains and for S. pallida isolates was higher than 90%. The band
sharing values observed in this study are within the range
of variation (70–85%) considered for strains within the same
species (Meyer, Maszewska and Sorrell 2001; de Oliveira et al.
2012). The inter-species variation was sufficient to clearly 170
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differentiate all species and to group all isolates accordingly.
This fingerprinting variation was also demonstrated previously
by Oliveira et al. (2012) for Sporothrix strains and for Candida spp.
(Correia et al. 2004). A dendrogram derived from analysis of theQ2
T3B profiles of all isolates splits the Sporothrix strains into six175
groups, showing a high correspondence between clusters and
Sporothrix species, with all isolates clustering with their respec-
tive control strain (Fig. 2). The CAL gene partial sequences of the
studied isolates along with sequences from the NCBI database,
AM398393.1 (S. mexicana), AM398382.1 (S. pallida), AM117444.1180
(S. schenckii), AM116899 (S. brasiliensis), AM116908 (S. globosa) and
AM747302 (S. luriei) were analyzed. The phylogenetic tree of the
CAL locus analyzed by neighbor joining revealed six distinct
clades representing the six species (Fig. 3).
Analyses of the results obtained with T3B fingerprinting185
identification showed 100% concordance with results from par-
tial sequencing of the CAL gene, confirming the accuracy of T3B
fingerprinting.
The identification of the Sporothrix species complex was
based on a polyphasic approach using a combination of phe-190
notypic methodologies and sequencing (Marimon et al. 2007; de
Oliveira et al. 2010, 2011; Dias et al. 2011), but phenotypic tests
proposed by Marimon et al. (2007) are often inconclusive or am-
biguous, and some species are too closely related to show clear-
cut differences (Oliveira et al. 2011; Rodrigues, de Hoog and de195
Camargo 2013; Zhou, Feng and de Hoog 2014). In this study, we
showed for the first time that T3B fingerprinting has the accu-
racy to identify all species of the Sporothrix complex. The inclu-
sion of the S. pallida is very important because, although ini-
tially described as environmental species (Marimon et al. 2007;200
de Meyer et al. 2008; Romeo, Scordino and Criseo 2011), re-
cently it was reported as etiologic agent of human sporotrichosis
(Morrison et al. 2013).
The T3B PCR fingerprinting technique is reproducible, reli-
able, rapid and less expensive, requires less technical expertise205
than sequencing and has a 100% agreement on species identi-
fication as the sequencing of the CAL locus. Thus, T3B finger-
printing could represent a useful tool in epidemiological studies
in order to obtain a better understanding of the role of these new
Sporothrix species in causing human infection.210
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GRAPHICAL ABSTRACT
In our study are described for first time the application of the PCR fingerprinting to
distinguish all species, clinical and environmental, of an important fungic complex,
Sporothrix spp.
